InterventionsReview

GLP-1 receptor agonists and podocyte senescence in diabetic kidney disease: structural pharmacology, mechanistic evidence, and multi-receptor agonism

Graphical abstract from Biochemical Pharmacology — Graphical abstractYue et al.

Biochemical Pharmacology

The paper

Yue H, Wang Y, Guo X et al.

Biochemical Pharmacology · 23 Sep 2026

doi.org/10.1016/j.bcp.2026.118495 PubMed 42777788

Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026